- Home
- COO vs BMRN Comparison
COO vs BMRN Comparison
Compare COO & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- BMRN
- Stock Information
- Founded
- COO 1980
- BMRN 1996
- Country
- COO United States
- BMRN United States
- Employees
- COO 16000
- BMRN N/A
- Industry
- COO Ophthalmic Goods
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- COO Health Care
- BMRN Health Care
- Exchange
- COO Nasdaq
- BMRN Nasdaq
- Market Cap
- COO 14.6B
- BMRN 12.1B
- IPO Year
- COO N/A
- BMRN 1999
- Fundamental
- Price
- COO $74.77
- BMRN $58.00
- Analyst Decision
- COO Strong Buy
- BMRN Buy
- Analyst Count
- COO 9
- BMRN 22
- Target Price
- COO $99.67
- BMRN $93.43
- AVG Volume (30 Days)
- COO 2.9M
- BMRN 2.1M
- Earning Date
- COO 08-27-2025
- BMRN 08-04-2025
- Dividend Yield
- COO N/A
- BMRN N/A
- EPS Growth
- COO 21.77
- BMRN 152.82
- EPS
- COO 2.07
- BMRN 2.71
- Revenue
- COO $3,988,200,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- COO $6.79
- BMRN $12.23
- Revenue Next Year
- COO $6.44
- BMRN $9.99
- P/E Ratio
- COO $36.12
- BMRN $21.48
- Revenue Growth
- COO 6.88
- BMRN 19.36
- 52 Week Low
- COO $65.00
- BMRN $52.93
- 52 Week High
- COO $112.38
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- COO 55.66
- BMRN 59.75
- Support Level
- COO $69.01
- BMRN $56.76
- Resistance Level
- COO $77.06
- BMRN $59.98
- Average True Range (ATR)
- COO 1.65
- BMRN 1.44
- MACD
- COO 0.85
- BMRN 0.62
- Stochastic Oscillator
- COO 74.38
- BMRN 81.47
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.